Allarity Therapeutics, Inc. (ALLR) Balance Sheet
ALLR balance sheet, 2025
December 31, 2025 · U.S. dollars$18.3M assets = $8.4M liabilities + $9.8M equity
Both columns are drawn to the same scale: what ALLR owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ALLR financial health
Descriptive bands, not a rating. Fiscal 2025.
ALLR balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $6.5M2016 | $18.3M2025 | +12.1%/yr | |
| Total liabilities | $1.3M2016 | $8.4M2025 | +22.7%/yr | |
| Shareholders’ equity | $5.2M2016 | $9.8M2025 | +7.3%/yr | |
| Cash & short-term investments | $2.1M2016 | $14.7M2025 | +24.3%/yr | |
| Total debt | $2.9M2018 | $1.4M2025 | −9.9%/yr | |
| Net cash (debt) | −$2.7M2018 | $13.3M2025 | +$15.9M | |
| Working capital | $3.0M2016 | $9.5M2025 | +$6.5M | |
| Current ratio | 3.272016 | 2.132025 | −1.14 | |
| Debt / equity | 0.102018 | 0.142025 | +0.04 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ALLR assets
ALLR liabilities and equity
ALLR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ALLR balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $14.7M | $19.5M | $166,000 | $2.0M | $19.9M | $298,000 | $1.5M | $237,378 | $536,027 | $2.1M |
| Cash & equivalents | $14.7M | $19.5M | $166,000 | $2.0M | $19.6M | $298,000 | $1.5M | $237,378 | $536,027 | $2.1M |
| Short-term investments | — | $72,000 | — | $0 | $350,000 | — | — | — | — | — |
| Receivables | $895,000 | $2.2M | $946,000 | $871,000 | $1.3M | $1.1M | $1.7M | $10.8M | $407,742 | $2,306 |
| Inventory | $0 | $0 | $0 | $0 | −$1.3M | $0 | −$2,000 | $0 | $168,898 | $34,694 |
| Other current assets | $2.3M | $579,000 | $859,000 | $2.1M | $1.5M | $293,000 | $163,000 | $0 | $193,075 | $2.3M |
| Total current assets | $17.9M | $22.3M | $2.0M | $5.0M | $21.4M | $1.7M | $3.3M | $2.2M | $1.3M | $4.4M |
| Property, plant & equipment (net) | $330,000 | $309,000 | $20,000 | $27,000 | $94,000 | $352,000 | $437,000 | $55,700 | $21,757 | $68,509 |
| Goodwill & intangible assets | $0 | $0 | $9.9M | $9.5M | $28.1M | $30.5M | $27.7M | $36.3M | $0 | $2.1M |
| Long-term investments | $0 | $0 | $0 | $0 | $350,000 | $845,000 | $137,000 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $765,201 | $28,327 |
| Total assets | $18.3M | $22.6M | $11.9M | $14.5M | $49.6M | $33.4M | $31.6M | $38.6M | $2.1M | $6.5M |
| Liabilities | ||||||||||
| Accounts payable | $4.3M | $4.2M | $8.4M | $6.3M | $698,000 | $2.1M | $2.2M | $1.9M | $472,368 | $1.3M |
| Short-term debt | $1.4M | $1.4M | $1.3M | $2.7M | $98,000 | $1.5M | $622,000 | $2.9M | — | — |
| Deferred revenue | — | — | $59,000 | — | $8.7M | — | — | — | — | — |
| Total current liabilities | $8.4M | $10.8M | $14.2M | $11.2M | $20.7M | $5.5M | $4.7M | $5.4M | $1.7M | $1.3M |
| Long-term debt | $0 | $0 | $0 | $1.1M | $979,000 | $880,000 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $0 | $8,000 | $107,000 | $376,000 | $427,000 | — | — | — |
| Other long-term liabilities | $0 | $0 | $446,000 | $349,000 | $9.2M | $139,000 | $6.0M | $5.3M | $0 | $0 |
| Total liabilities | $8.4M | $10.8M | $14.6M | $12.7M | $30.8M | $6.6M | $10.7M | $10.7M | $1.7M | $1.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $3,000 | $1,000 | — | $2,000 | $1,000 | $1.6M | $924,000 | $386,066 | $195,812 | $154,805 |
| Retained earnings (deficit) | −$130.2M | −$119.0M | −$94.5M | −$82.5M | −$66.5M | −$37.4M | −$32.4M | −$9.4M | −$7.1M | — |
| Accumulated other comprehensive income | −$1.0M | −$354,000 | −$411,000 | −$721,000 | −$600,000 | $1.4M | −$1.1M | $18,566 | −$12,571 | −$4.3M |
| Total shareholders' equity | $9.8M | $11.8M | −$2.8M | $1.9M | $18.8M | $26.9M | $20.9M | $27.9M | $394,043 | $5.2M |
| Key figures | ||||||||||
| Total debt | $1.4M | $1.4M | $1.3M | $3.7M | $1.1M | $1.8M | $963,000 | $2.9M | — | — |
| Net cash (debt) | $13.3M | $18.2M | −$1.1M | −$1.7M | $18.8M | −$1.5M | $561,000 | −$2.7M | — | — |
| Working capital | $9.5M | $11.5M | −$12.2M | −$6.3M | $685,000 | −$3.8M | −$1.4M | −$3.2M | −$392,915 | $3.0M |
| Tangible book value | $9.8M | $11.8M | −$12.6M | −$7.7M | −$9.4M | −$3.6M | −$6.8M | −$8.4M | $394,043 | $3.1M |
| Book value per share | $0.68 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 14.4M | — | — | — | — | — | — | — | — | — |
| Current ratio | 2.13 | 2.06 | 0.14 | 0.44 | 1.03 | 0.31 | 0.71 | 0.41 | 0.77 | 3.27 |
| Quick ratio | 1.85 | 2.01 | 0.08 | 0.26 | 1.03 | 0.26 | 0.67 | 2.03 | 0.56 | 1.55 |
| Debt / equity | 0.14 | 0.11 | — | 1.98 | 0.06 | 0.07 | 0.05 | 0.10 | — | — |
| Equity / assets | 53.8% | 52.1% | −23.2% | 13.0% | 37.8% | 80.4% | 66.1% | 72.3% | 18.8% | 79.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $17.0M | $19.8M | $14.7M | $16.9M | $17.8M | $25.2M | $19.5M | $18.5M | $19.2M | $312,000 | $166,000 | $1.4M |
| Cash & equivalents | $17.0M | $19.8M | $14.7M | $16.9M | $17.8M | $25.2M | $19.5M | $18.5M | $19.2M | $312,000 | $166,000 | $1.4M |
| Short-term investments | — | — | — | — | — | — | $72,000 | — | — | — | — | — |
| Receivables | $1.3M | $1.1M | $895,000 | $1.7M | $1.6M | $1.1M | $2.2M | $1.7M | $1.6M | $1.3M | $946,000 | $1.6M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$1.6M |
| Other current assets | $13.4M | $13.6M | $2.3M | $1.9M | $1.5M | $3.1M | $579,000 | $251,000 | $497,000 | $652,000 | $859,000 | $3.0M |
| Total current assets | $31.7M | $34.5M | $17.9M | $20.5M | $20.9M | $29.4M | $22.3M | $20.4M | $21.3M | $2.3M | $2.0M | $4.4M |
| Property, plant & equipment (net) | $386,000 | $420,000 | $330,000 | $330,000 | $322,000 | $308,000 | $309,000 | $12,000 | $17,000 | $18,000 | $20,000 | $29,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9.6M | $9.7M | $9.9M | $9.5M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $32.1M | $34.9M | $18.3M | $20.8M | $21.2M | $29.7M | $22.6M | $20.4M | $30.9M | $12.0M | $11.9M | $13.9M |
| Liabilities | ||||||||||||
| Accounts payable | $4.1M | $4.2M | $4.3M | $4.6M | $4.6M | $4.3M | $4.2M | $4.7M | $7.8M | $11.1M | $8.4M | $6.3M |
| Short-term debt | $22.3M | $21.5M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.3M | $1.3M | $2.7M | $1.3M | — |
| Deferred revenue | — | — | — | — | — | — | — | — | $57,000 | $43,000 | $59,000 | — |
| Total current liabilities | $28.6M | $28.0M | $8.4M | $8.8M | $9.0M | $11.1M | $10.8M | $7.4M | $10.6M | $18.0M | $14.2M | $15.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.2M |
| Lease obligations | — | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $432,000 | $432,000 | $446,000 | $343,000 |
| Total liabilities | $28.6M | $28.0M | $8.4M | $8.8M | $9.0M | $11.1M | $10.8M | $7.4M | $11.0M | $18.4M | $14.6M | $17.3M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $1,000 | — | $3,000 | — | — | — |
| Retained earnings (deficit) | −$136.4M | −$132.9M | −$130.2M | −$126.8M | −$124.0M | −$121.7M | −$119.0M | −$111.5M | −$99.9M | −$98.3M | −$94.5M | −$92.7M |
| Accumulated other comprehensive income | −$1.3M | −$1.1M | −$1.0M | −$2.3M | −$2.5M | −$630,000 | −$354,000 | −$693,000 | −$530,000 | −$386,000 | −$411,000 | −$758,000 |
| Total shareholders' equity | $3.5M | $6.9M | $9.8M | $12.0M | $12.2M | $18.7M | $11.8M | $13.0M | $19.8M | −$6.5M | −$2.8M | −$3.4M |
| Key figures | ||||||||||||
| Total debt | $22.3M | $21.5M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.3M | $1.3M | $2.7M | $1.3M | $1.2M |
| Net cash (debt) | −$5.3M | −$1.7M | $13.3M | $15.5M | $16.4M | $23.8M | $18.2M | $17.1M | $17.9M | −$2.4M | −$1.1M | $232,000 |
| Working capital | $3.1M | $6.5M | $9.5M | $11.7M | $11.8M | $18.4M | $11.5M | $13.0M | $10.7M | −$15.7M | −$12.2M | −$11.4M |
| Tangible book value | $3.5M | $6.9M | $9.8M | $12.0M | $12.2M | $18.7M | $11.8M | $13.0M | $10.3M | −$16.1M | −$12.6M | −$12.8M |
| Book value per share | $0.22 | $0.43 | $0.68 | $0.81 | $0.78 | — | — | — | — | — | — | — |
| Shares outstanding | 15.9M | 16.0M | 14.4M | 14.7M | 15.5M | — | — | — | — | — | — | — |
| Current ratio | 1.11 | 1.23 | 2.13 | 2.33 | 2.31 | 2.66 | 2.06 | 2.75 | 2.01 | 0.13 | 0.14 | 0.28 |
| Quick ratio | 0.64 | 0.75 | 1.85 | 2.11 | 2.15 | 2.38 | 2.01 | 2.71 | 1.96 | 0.09 | 0.08 | 0.19 |
| Debt / equity | 6.30 | 3.11 | 0.14 | 0.12 | 0.11 | 0.07 | 0.11 | 0.10 | 0.07 | — | — | — |
| Equity / assets | 11.0% | 19.8% | 53.8% | 57.8% | 57.4% | 62.8% | 52.1% | 63.6% | 64.2% | −54.1% | −23.2% | −24.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.
ALLR financial position
At the end of fiscal 2025 (December 31, 2025), Allarity Therapeutics had total assets of $18.3 million (down 19.4% from a year earlier), total liabilities of $8.4 million and shareholders' equity of $9.8 million. It held $14.7 million in cash and short-term investments against $1.4 million of debt, a net cash position of $13.3 million. Its current ratio was 2.13. In the latest quarter (ended June 30, 2026) total assets were $32.1 million and equity $3.5 million.
Related: ALLR income statement, ALLR cash flow statement, ALLR key metrics. See the ALLR stock overview for the latest quote and news.
ALLR balance sheet FAQ
What are Allarity Therapeutics's total assets?
Allarity Therapeutics reported total assets of $18.3 million at the end of fiscal 2025 (December 31, 2025), compared with $22.6 million a year earlier.
How much debt does Allarity Therapeutics have?
Allarity Therapeutics had $1.4 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.14.
How much cash does Allarity Therapeutics have?
Allarity Therapeutics held $14.7 million in cash and short-term investments at the end of fiscal 2025; with $1.4 million of debt that is net cash of $13.3 million.
What is Allarity Therapeutics's book value?
Allarity Therapeutics's shareholders' equity (book value) was $9.8 million at the end of fiscal 2025, or $0.68 per share.
What is Allarity Therapeutics's current ratio?
Allarity Therapeutics had current assets of $17.9 million and current liabilities of $8.4 million, a current ratio of 2.13 (it can cover its short-term obligations).